CD8A and interstitial lung disease: To further investigate these CD8+ MPXV-specific T cells in convalescent individuals, we carried out SmartSeq2 scRNAseq analysis to investigate the transcriptome and TCR repertoire of ILD-specific T cells from convalescent individuals compared to samples 28 days after vaccination, the timepoint when sufficient tetramer+ T cells were isolated.